According to a new market report published by Transparency Market Research “G-Protein Coupled Receptors (GPCRs) Market (Assay Type: cAMP Assays, Calcium Level Detection Assays, GTPγS Binding Assays, Reporter Gene Assays, Receptor Internalization Assays, and cGMP Assays; Therapeutic Areas: Cardiovascular System, Central Nervous System, Respiratory System, Immune System, Reproductive System, Oncology, and Others): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2022,” the global GPCRs market was valued at USD 1,635.1 million in 2013 and is expected to grow at a CAGR of 8.8 % from 2014 to 2022, to reach an estimated value of USD 3,533.4 million in 2022.
Browse the full G-Protein Coupled Receptors (GPCRs) Market Report: http://www.transparencymarketresearch.com/g-protein-coupled-receptors-market.html
G-protein coupled receptors (GPCRs) form the largest and most diverse group of cell surface receptors in eukaryotes. GPCRs are expressed in all body systems and tissues with discrete expression patterns. They control a wide variety of physiological processes such as chemotaxis, neurotransmission, inflammation, and cell proliferation. Therefore, GPCRs have been implicated in majority of disease classes such as cancer, cardiovascular diseases, respiratory diseases, and immune diseases. Considering their importance in disease and health, and the ability for therapeutic intervention by molecular drugs, GPCRs represent a major and the most successful class of drug targets in the human genome.
The GPCRs market is growing steadily at a CAGR of 8.8% due their rising demand in drug discovery and ADME toxicology studies, increased government initiatives for the development of new and improved drugs, and high prevalence of chronic diseases such as cardiovascular diseases, respiratory disorders, and breast cancer. With improved understanding of cellular mechanisms and introduction of advanced instrumentation and assay platforms, label-free biosensor-based cellular assay technologies are expected to become an active area for GPCR screening. Rising interest and increasing commercial investment in GPCRs in areas such as drug targets, high-throughput screening, orphan receptors and biosensors would further contribute to higher attention on the assay development market.
Geographically, the GPCRs market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). These geographic regions have been further divided into major national markets, viz. North America (the U.S. and Canada), Europe (Germany, the U.K., France, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of Asia Pacific) and Rest of the World that has been further subdivided into three regions: Latin America, the Middle East, and Africa. North America is the largest market for GPCRs that accounts for a share of 41.2% of the global GPCRs market in 2013. High prevalence of cardiovascular and respiratory diseases, financial capability to purchase expensive devices, and high awareness about advanced assay procedures are the major factors contributing to the growth of the GPCRs market in North America.
Browse the full Press Release of G-Protein Coupled Receptors (GPCRs) Market:http://www.transparencymarketresearch.com/pressrelease/g-protein-coupled-receptors-market.htm
Europe held the second largest share of the global GPCRs market in 2013. However, the region is expected to lose its market share by 2022. Factors such as high prevalence of cardiovascular and respiratory diseases, rapidly aging population, high expenditure on research and development, and demand for new and technologically advanced products are attributed to high growth rate in the region. On the other hand, Asia Pacific offers greater opportunities than any other region with respect to GPCR assays due to expansion by market players, increasing research and development in health care, rising prevalence of cancer and other chronic diseases, and significant growth in medical tourism. In addition, Latin America, Africa and the Middle East present huge potential in the GPCRs market majorly due to high prevalence of various diseases, improving health care facilities, and geographical expansion of global players in these regions.
Thermo Fisher Scientific, Inc., EMD (Merck) Millipore, Becton, Dickinson and Company, PerkinElmer, Inc., Cisbio Bioassays, Enzo Life Sciences, Inc., DiscoveRx Corporation, Sigma-Aldrich Corporation, Qiagen N.V., Promega Corporation, Abcam plc, and HD Biosciences Co. Ltd. are the major players operating in the global GPCRs market. Among these, Thermo Fisher Scientific, EMD (Merck) Millipore, Becton, Dickinson and Company, PerkinElmer, Inc. and Sigma-Aldrich Corporation operate in most of the segments of GPCRs market. Most of these players are engaged in continuous innovation, and develop technologically advanced and/or improved GPCR assays and assay systems in order to maintain their position in the global market.
The global GPCRs market is segmented as follows:
GPCRs Market, by Assay Type
- Calcium Level Detection Assays
- GTPγS Binding Assays\
- cGMP Assays
- Reporter Gene Assays
- Receptor Internalization Assay
- cAMP Assays
GPCRs Market, by Therapeutic Area
- Cardiovascular System
- Central Nervous System
- Respiratory System
- Immune System
- Reproductive System
GPCRs Market, by Geography
- Rest of Europe
- Rest of Asia Pacific
Rest of the World (RoW)
- Latin America
- Middle East
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453